电子处方系统抗菌药物管理设计优先级:142名英国感染专科医师调查
该研究通过名义小组技术开发问卷,调查英国感染专科人员对电子处方系统(EPMA)中抗菌药物管理(AMS)软件功能的优先级意见。142份可分析回复显示,药师比微生物学家更重视适应证提示、过敏检查等功能,89%受访者将「软停止」功能评为必要或高优先级,共识认为EPMA对患者安全和AMS有积极影响。
要点
- 药师比微生物学家更重视适应证提示、过敏检查、治疗方案等AMS功能。
- 89%受访者将「软停止」功能评为必要或高优先级。
- EPMA预期对患者安全和AMS影响最大,对艰难梭菌感染和耐药影响最小。
核心结论
- 感染专科人员对EPMA的医疗获益看法存在差异,但对患者安全和AMS的积极影响有共识。
研究设计与样本
- 横断面问卷调查,通过专业网络邮件发送,共收到164份回复,其中142份可分析。
主要发现
- 受访者主要为感染专科药师(48%)和医学微生物学家(37%)。
- 药师中59%有本院EPMA使用经验,微生物学家中为35%。
- 药师比微生物学家更重视适应证提示(P < 0.001)、过敏检查(P = 0.003)、治疗方案(P = 0.003)、药物-适应证不匹配警报(P = 0.031)和疗程延长警报(P = 0.041)。
- 药师比微生物学家更不重视成人剂量检查(P = 0.02)和相互作用检查(P < 0.05)。
- 89%受访者将「软停止」功能评为必要或高优先级。
关键数值与推荐
- 「软停止」功能被89%受访者评为必要或高优先级。
临床怎么用
- 设计EPMA系统时应优先考虑适应证提示、过敏检查、治疗方案、不匹配警报和疗程延长警报等AMS功能。
- 「软停止」功能可作为EPMA中支持AMS的高优先级设计要素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The implementation of electronic prescribing and medication administration (EPMA) systems is a priority for hospitals and a potential component of antimicrobial stewardship (AMS). OBJECTIVES: To identify software features within EPMA systems that could potentially facilitate AMS and to survey practising UK infection specialist healthcare professionals in order to assign priority to these software features. METHODS: A questionnaire was developed using nominal group technique and transmitted via email links through professional networks. The questionnaire collected demographic data, information on priority areas and anticipated impact of EPMA. Responses from different respondent groups were compared using the Mann-Whitney U -test. RESULTS: Responses were received from 164 individuals (142 analysable). Respondents were predominantly specialist infection pharmacists (48%) or medical microbiologists (37%). Of the pharmacists, 59% had experience of EPMA in their hospitals compared with 35% of microbiologists. Pharmacists assigned higher priority to indication prompt ( P < 0.001), allergy checker ( P = 0.003), treatment protocols ( P = 0.003), drug-indication mismatch alerts ( P = 0.031) and prolonged course alerts ( P = 0.041) and lower priority to a dose checker for adults ( P = 0.02) and an interaction checker ( P < 0.05) than microbiologists. A 'soft stop' functionality was rated essential or high priority by 89% of respondents. Potential EPMA software features were expected to have the greatest impact on stewardship, treatment efficacy and patient safety outcomes with lowest impact on Clostridium difficile infection, antimicrobial resistance and drug expenditure. CONCLUSIONS: The survey demonstrates key differences in health professionals' opinions of potential healthcare benefits of EPMA, but a consensus of anticipated positive impact on patient safety and AMS.
引用
- Hand KS, Cumming D, Hopkins S, et al. Electronic prescribing system design priorities for antimicrobial stewardship: a cross-sectional survey of 142 UK infection specialists. J Antimicrob Chemother. 2017. PMID: 27999065. doi:10.1093/jac/dkw524
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。